NO141207C - Analogifremgangsmaate for fremstilling av fysiologisk aktive fenylalkylaminer - Google Patents

Analogifremgangsmaate for fremstilling av fysiologisk aktive fenylalkylaminer

Info

Publication number
NO141207C
NO141207C NO751491A NO751491A NO141207C NO 141207 C NO141207 C NO 141207C NO 751491 A NO751491 A NO 751491A NO 751491 A NO751491 A NO 751491A NO 141207 C NO141207 C NO 141207C
Authority
NO
Norway
Prior art keywords
phenylalkylamines
preparation
physiologically active
analogy procedure
analogy
Prior art date
Application number
NO751491A
Other languages
English (en)
Norwegian (no)
Other versions
NO751491L (pl
NO141207B (no
Inventor
Kurt Schromm
Anton Mentrup
Ernst Otto Renth
Ludwig Pichler
Original Assignee
Boehringer Sohn Ingelheim
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Sohn Ingelheim filed Critical Boehringer Sohn Ingelheim
Publication of NO751491L publication Critical patent/NO751491L/no
Publication of NO141207B publication Critical patent/NO141207B/no
Publication of NO141207C publication Critical patent/NO141207C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C275/00—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C275/28—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C07C275/40—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton being further substituted by nitrogen atoms not being part of nitro or nitroso groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO751491A 1974-04-27 1975-04-25 Analogifremgangsmaate for fremstilling av fysiologisk aktive fenylalkylaminer NO141207C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2420618A DE2420618C2 (de) 1974-04-27 1974-04-27 Aminoalkylanilide, Verfahren zu ihrer Herstellung sowie pharmazeutische Zubereitungen, die diese Aminoalkylanilide enthalten

Publications (3)

Publication Number Publication Date
NO751491L NO751491L (pl) 1975-10-28
NO141207B NO141207B (no) 1979-10-22
NO141207C true NO141207C (no) 1980-01-30

Family

ID=5914207

Family Applications (1)

Application Number Title Priority Date Filing Date
NO751491A NO141207C (no) 1974-04-27 1975-04-25 Analogifremgangsmaate for fremstilling av fysiologisk aktive fenylalkylaminer

Country Status (27)

Country Link
US (1) US4015011A (pl)
JP (1) JPS5828269B2 (pl)
AT (1) AT350529B (pl)
BE (1) BE828430A (pl)
BG (2) BG26372A4 (pl)
CA (1) CA1061357A (pl)
CH (3) CH614697A5 (pl)
CS (2) CS216828B2 (pl)
DD (1) DD122374A5 (pl)
DE (1) DE2420618C2 (pl)
DK (1) DK180675A (pl)
ES (7) ES437032A1 (pl)
FI (1) FI63931C (pl)
FR (1) FR2268520B1 (pl)
GB (1) GB1501436A (pl)
HU (1) HU172615B (pl)
IE (1) IE42119B1 (pl)
IL (1) IL47170A (pl)
NL (1) NL7504917A (pl)
NO (1) NO141207C (pl)
PH (2) PH11982A (pl)
PL (2) PL96308B1 (pl)
RO (2) RO70894A (pl)
SE (2) SE411205B (pl)
SU (2) SU555843A3 (pl)
YU (1) YU105275A (pl)
ZA (1) ZA752685B (pl)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4163060A (en) * 1974-04-08 1979-07-31 U.S. Philips Corporation Aralkylamino carboxylic acids and derivatives having spasmolytic activity
US4146645A (en) * 1974-04-27 1979-03-27 Boehringer Ingelheim Gmbh Hypertensive phenylalkylamines and salts thereof
US4145363A (en) * 1975-02-05 1979-03-20 Yamanouchi Pharmaceutical Co., Ltd. 4-Carbamoylamino-α-aminomethylbenzyl alcohol derivatives
US4088785A (en) * 1976-03-25 1978-05-09 William H. Rorer, Inc. Amidinoureas for the treatment of cardinascular disorders
US4754047A (en) * 1979-08-16 1988-06-28 American Cyanamid Company Phenylethanolamine derivatives and acid addition salts thereof for enhancing the growth rate of meat-producing animals and/or improving the efficiency of feed utilization thereby
US4477470A (en) * 1983-10-20 1984-10-16 Smithkline Beckman Corporation Method for producing diuresis using m-amino-α-methylphenethylamine
JPS6155683U (pl) * 1984-09-17 1986-04-14
JPS61130876U (pl) * 1984-09-18 1986-08-15
ES8606847A1 (es) * 1984-11-08 1986-05-16 Syntex Inc Procedimiento para la preparacion de derivados de dialquila-mino-etilanilina antihipertensos
US4752621A (en) * 1985-04-11 1988-06-21 Syntex (U.S.A.) Inc. Arylalkyl amines useful for lowering intraocular pressure
US4798687A (en) * 1987-02-06 1989-01-17 Pennwalt Corporation 2-Amino-N-[1,2-Diphenyl-1-(thifluoromethyl)ethyl]acetamide derivatives
JPH01116184U (pl) * 1988-01-29 1989-08-04
JPH01116183U (pl) * 1988-01-29 1989-08-04
US5741818A (en) * 1995-06-07 1998-04-21 University Of Saskatchewan Semicarbazones having CNS activity and pharmaceutical preparations containing same
ATE289295T1 (de) * 1997-04-22 2005-03-15 Euro Celtique Sa Die verwendung von durch carbozyklische und heterozyklische reste substituierte semicarbazonen und thiosemicarbazonen als natriumkanalblocker
ATE359993T1 (de) * 1997-08-05 2007-05-15 Pola Chem Ind Inc Aminderivate, verfahren zu ihrer herstellung und ihre verwendung als antimykotische mittel

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL123536C (pl) * 1963-07-09

Also Published As

Publication number Publication date
CS216827B2 (en) 1982-11-26
DD122374A5 (pl) 1976-10-05
PL96224B1 (pl) 1977-12-31
HU172615B (hu) 1978-11-28
ES452510A1 (es) 1977-11-01
PH11982A (en) 1978-10-04
ES437032A1 (es) 1977-04-16
SU555843A3 (ru) 1977-04-25
DE2420618C2 (de) 1982-09-16
SE7504858L (sv) 1975-10-28
BE828430A (fr) 1975-10-27
GB1501436A (en) 1978-02-15
JPS50149630A (pl) 1975-11-29
ES452514A1 (es) 1977-11-01
ES452515A1 (es) 1977-11-01
ES452512A1 (es) 1977-11-01
SE411205B (sv) 1979-12-10
US4015011A (en) 1977-03-29
CH616146A5 (pl) 1980-03-14
RO70894A (ro) 1982-02-26
NO751491L (pl) 1975-10-28
BG26372A4 (bg) 1979-03-15
PL96308B1 (pl) 1977-12-31
PH14732A (en) 1981-11-19
IL47170A0 (en) 1975-06-25
DE2420618A1 (de) 1975-11-13
FI751199A (pl) 1975-10-28
RO81766A (ro) 1983-06-01
YU105275A (en) 1982-02-28
ZA752685B (en) 1976-12-29
NL7504917A (nl) 1975-10-29
IL47170A (en) 1980-07-31
AT350529B (de) 1979-06-11
BG27738A3 (en) 1979-12-12
FR2268520B1 (pl) 1982-02-12
CS216828B2 (en) 1982-11-26
SU606549A3 (ru) 1978-05-05
CA1061357A (en) 1979-08-28
CH616401A5 (pl) 1980-03-31
NO141207B (no) 1979-10-22
ES452513A1 (es) 1977-11-01
FI63931C (fi) 1983-09-12
FR2268520A1 (pl) 1975-11-21
DK180675A (da) 1975-10-28
FI63931B (fi) 1983-05-31
IE42119B1 (en) 1980-06-04
IE42119L (en) 1975-10-27
ATA247875A (de) 1978-11-15
SE7810002L (sv) 1978-09-22
JPS5828269B2 (ja) 1983-06-15
CH614697A5 (pl) 1979-12-14
ES452511A1 (es) 1977-11-01
AU8051075A (en) 1976-10-28
RO81766B (ro) 1983-05-30

Similar Documents

Publication Publication Date Title
NO149106C (no) Analogifremgangsmaate for fremstilling av farmakologisk aktive benzcykloamider
NO143460C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive benzomorfaner.
NO141800C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive benzomorfaner.
SE7513085L (sv) Forfarande for framstellning av etrar
NO141207C (no) Analogifremgangsmaate for fremstilling av fysiologisk aktive fenylalkylaminer
NO142838C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive isokinolinderivater
SE421209B (sv) Analogiforfarande for framstellning av tienobensodiazepiner
SE7506160L (sv) Forfarande for framstellning av n-cykloalkylmetyldekahydroisokinoline
NO141894C (no) Analogifremgangsmaate for fremstilling av farmakologisk aktive pyridobenzodiazepinoner
NO143064C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive hydroksyalkylxantiner
NO143625C (no) Analogifremgangsmaate for fremstilling av 2-metoksy-benzamider
SE431207B (sv) Forfarande for framstellning av tiazolidinderivat
SE425790B (sv) Forfarande for framstellning av polylaurinlactam
IT1032857B (it) Procedimento per la preparazione del perclorometilmercaptano
SE411453B (sv) Forfarande for framstellning av 3-fluorcefalosporiner
SE403477B (sv) Forfarande for famstellning av substituerade indoleniner
NO145238C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive dihydrokarbostyril-derivater
SE421422B (sv) Analogiforfarande for framstellning av 6-metyl-8beta-isocyanometyl-ergolin
SE426827B (sv) Nytt forfarande for framstellning av 7beta-acylamino-7alfa-alkoxicefalosporiner
SE7506827L (sv) Forfarande for framstellning av nitrilhaltig polymer
NO146672C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive cinnolinderivater
SE7511801L (sv) Forfarande for framstellning av ympsampolymerisat
NO142403C (no) Analogifremgangsmaate for fremstilling av farmakologisk aktive isokinoliner.
NO139684C (no) Fremgangsmaate for fremstilling av n,n-diallyldikloracetamid
NO145074C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive dibenzazepinderivater